Drug boosting 'survival rates of terminally ill patients' to be here within months | The Sun

MEN with terminal prostate cancer could benefit from a new drug.

Lutetium, which boosted survival by four months in those whose disease had spread, is safe and effective to use.

It was approved by The Medicines and Healthcare Regulatory Agency.

The drugs watchdog is set to decide whether to recommend an NHS rollout in the autumn.

More than 52,000 men a year are diagnosed with prostate cancer and 12,000 die.

Around 3,500 develop advanced disease that does not respond to routine treatment.


I’m a doctor – here’s the 5 common habits that are bad for your penis

How your LEG pain could actually be a sign of common cancer in young people

Lutetium, given intravenously, binds to cancer cells to deliver a radioactive payload that destroys the tumour.

Prof Johann de Bono, of West London’s Royal Marsden Hospital, said: “This is a major clinical advancement.”

Most read in The Sun

Idiot parked DIRECTLY in front of my drive – everyone's saying the same thing

Ekin-Su signs biggest fashion deal in Love Island history worth over £1m

Carol Vorderman appears to post NAKED TikTok video during holiday in Portugal

Mum, 40, & her dad, 78, killed in crash that's left her daughter critical

    Source: Read Full Article